News on noninvasive prenatal testing, carrier screening, and preimplantation genetic screening.
Several analysts said that the decision by UHC, the largest private payor in the US, will especially benefit Natera.
At an AMP virtual meeting workshop, a Mayo Clinic lab director offered advice on what diseases to include, how to handle VUSs, and other considerations for ECS.
The firm said it will dispute the claim of overpayment and will separately negotiate with the undisclosed payor for in-network status.
In a study involving 1,300 blood samples from pregnant women, Myriad researchers demonstrated that their method could increase the fetal fraction for almost all.
The company performed 84,067 total tests in Q3 but missed the analysts' average estimates on the top and bottom lines.
